このアイテムのアクセス数: 343

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
39_1209.pdf1.85 MBAdobe PDF見る/開く
タイトル: 浸潤性膀胱癌に対する温熱化学療法
その他のタイトル: Studies of combined treatment of radiofrequency hyperthermia with anticancer agents or irradiation for invasive bladder cancer
著者: 打林, 忠雄  KAKEN_name
李, 秀雄  KAKEN_name
久住, 治男  KAKEN_name
内藤, 克輔  KAKEN_name
遠藤, 良夫  KAKEN_name
野口, 美香  KAKEN_name
田中, 基裕  KAKEN_name
佐々木, 琢磨  KAKEN_name
著者名の別形: Uchibayashi, Tadao
Lee, Soo-Woong
Hisazumi, Haruo
Naito, Katsusuke
Endo, Yoshio
Noguchi, Mika
Tanaka, Motohiro
Sasaki, Takuma
キーワード: Colony forming assay
Chick embryo assay
Chemohyperthermia
Invasive bladder cancer
発行日: Dec-1993
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 39
号: 12
開始ページ: 1209
終了ページ: 1213
抄録: Using an in vitro colony forming assay system, the cytotoxic effects of anticancer agents alone, adriamycin (ADM) and bleomycin (BLM), and the combined effects of hyperthermia and anticancer agents on cultivated KK-47 cells were investigated. When the hyperthermia was combined with various concentrations of ADM ranging from 0.005 to 0.1 microgram/ml and BLM from 0.01 to 1.0 microgram/ml, enhanced cell killing effects were obtained at the concentration of less than 0.02 microgram/ml of ADM and with an increase of BLM concentration. In DNA specimens obtained from the livers of chick embryos inoculated with human tumor cultivated cells, the polymerase chain reaction technique was used to amplify a DNA fragment specific to the beta-globin gene. By detecting these amplified DNA fragments, the feasibility of efficiently detecting metastatic cells present in chick embryo was demonstrated in vivo. Hyperthermic therapy showed inhibitory effects on the growth of metastasized cultivated cells in a thermal dose-dependent manner. Combination therapy of ADM, mitomycin and carboplatin and hyperthermia had an enhanced inhibitory activity on the growth of metastasized cultivated human tumor cells derived from bladder cancer. Hyperthermia using radiofrequency-capacitive heating in combination with irradiation or anticancer agents, was performed in a total of 56 patients with T2 to T4 invasive urinary bladder cancer. A tumor regression rate of 50 percent or more was obtained in 21 of these 56 patients. We have to follow up the patients for longer periods more precisely to evaluate the role of these treatments.
URI: http://hdl.handle.net/2433/117999
PubMed ID: 7506870
出現コレクション:Vol.39 No.12

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。